Milestone Pharmaceuticals Inc
NASDAQ:MIST
Cash Flow Statement
Cash Flow Statement
Milestone Pharmaceuticals Inc
| Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||||||||||||||||||||||||
| Net Income |
(23)
|
(29)
|
(40)
|
(47)
|
(55)
|
(61)
|
(60)
|
(60)
|
(50)
|
(46)
|
(32)
|
(35)
|
(43)
|
(44)
|
(62)
|
(62)
|
(58)
|
(59)
|
(59)
|
(59)
|
(60)
|
(55)
|
(48)
|
(43)
|
(42)
|
(52)
|
(56)
|
(58)
|
|
| Depreciation & Amortization |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Stock-Based Compensation |
1
|
1
|
1
|
1
|
1
|
2
|
3
|
4
|
5
|
5
|
6
|
7
|
7
|
8
|
9
|
9
|
9
|
9
|
9
|
10
|
10
|
9
|
8
|
6
|
6
|
6
|
6
|
5
|
|
| Other Non-Cash Items |
1
|
1
|
1
|
1
|
1
|
2
|
3
|
4
|
5
|
5
|
6
|
7
|
7
|
8
|
9
|
9
|
9
|
9
|
10
|
11
|
12
|
12
|
11
|
9
|
9
|
9
|
9
|
9
|
|
| Change in Working Capital |
2
|
(2)
|
(1)
|
4
|
3
|
5
|
(2)
|
(3)
|
(6)
|
(4)
|
(1)
|
(2)
|
2
|
2
|
3
|
1
|
(3)
|
(2)
|
(0)
|
(2)
|
1
|
2
|
1
|
2
|
4
|
9
|
6
|
6
|
|
| Cash from Operating Activities |
(21)
N/A
|
(31)
-48%
|
(39)
-26%
|
(42)
-7%
|
(51)
-22%
|
(55)
-7%
|
(60)
-9%
|
(59)
+2%
|
(51)
+13%
|
(45)
+11%
|
(28)
+39%
|
(30)
-7%
|
(33)
-12%
|
(35)
-4%
|
(50)
-43%
|
(52)
-4%
|
(52)
-1%
|
(52)
+0%
|
(49)
+7%
|
(49)
-1%
|
(46)
+6%
|
(41)
+11%
|
(37)
+11%
|
(32)
+14%
|
(29)
+9%
|
(34)
-17%
|
(40)
-19%
|
(43)
-7%
|
|
| Investing Cash Flow | |||||||||||||||||||||||||||||
| Capital Expenditures |
(0)
|
0
|
(0)
|
(0)
|
(0)
|
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Other Items |
16
|
9
|
(34)
|
(21)
|
0
|
0
|
3
|
(26)
|
(70)
|
(58)
|
(6)
|
41
|
70
|
50
|
15
|
(25)
|
(57)
|
(19)
|
(32)
|
(26)
|
5
|
(52)
|
(15)
|
3
|
8
|
69
|
69
|
28
|
|
| Cash from Investing Activities |
16
N/A
|
9
-44%
|
(34)
N/A
|
(21)
+37%
|
(0)
+98%
|
0
N/A
|
3
N/A
|
(26)
N/A
|
(70)
-168%
|
(58)
+17%
|
(6)
+90%
|
41
N/A
|
70
+71%
|
50
-29%
|
15
-70%
|
(25)
N/A
|
(57)
-127%
|
(19)
+66%
|
(32)
-68%
|
(26)
+19%
|
5
N/A
|
(52)
N/A
|
(15)
+72%
|
3
N/A
|
8
+216%
|
69
+732%
|
69
+1%
|
28
-60%
|
|
| Financing Cash Flow | |||||||||||||||||||||||||||||
| Net Issuance of Common Stock |
80
|
80
|
167
|
166
|
85
|
85
|
(0)
|
25
|
73
|
73
|
78
|
53
|
5
|
5
|
0
|
3
|
3
|
3
|
3
|
1
|
1
|
28
|
28
|
27
|
28
|
(0)
|
0
|
47
|
|
| Net Issuance of Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
50
|
50
|
50
|
50
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other |
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(3)
|
(3)
|
(3)
|
2
|
5
|
5
|
5
|
(0)
|
0
|
3
|
|
| Cash from Financing Activities |
80
N/A
|
80
N/A
|
166
+107%
|
165
0%
|
85
-48%
|
85
+0%
|
(0)
N/A
|
25
N/A
|
73
+192%
|
73
0%
|
78
+6%
|
53
-32%
|
5
-90%
|
5
+1%
|
0
-94%
|
3
+855%
|
3
+4%
|
53
+1 625%
|
50
-5%
|
48
-5%
|
48
0%
|
30
-38%
|
32
+8%
|
32
-1%
|
32
+0%
|
(0)
N/A
|
0
N/A
|
49
+17 826%
|
|
| Change in Cash | |||||||||||||||||||||||||||||
| Net Change in Cash |
75
N/A
|
58
-23%
|
93
+60%
|
102
+10%
|
34
-67%
|
31
-10%
|
(57)
N/A
|
(60)
-4%
|
(48)
+20%
|
(30)
+37%
|
44
N/A
|
65
+45%
|
42
-35%
|
20
-51%
|
(35)
N/A
|
(74)
-115%
|
(107)
-44%
|
(18)
+83%
|
(31)
-68%
|
(27)
+11%
|
6
N/A
|
(64)
N/A
|
(19)
+70%
|
3
N/A
|
12
+295%
|
35
+203%
|
29
-16%
|
34
+16%
|
|
| Free Cash Flow | |||||||||||||||||||||||||||||
| Free Cash Flow |
(21)
N/A
|
(31)
-47%
|
(39)
-26%
|
(42)
-8%
|
(52)
-22%
|
(55)
-6%
|
(60)
-9%
|
(59)
+1%
|
(51)
+14%
|
(45)
+11%
|
(28)
+39%
|
(30)
-7%
|
(33)
-12%
|
(35)
-4%
|
(50)
-44%
|
(52)
-5%
|
(53)
-1%
|
(53)
+0%
|
(49)
+7%
|
(50)
-1%
|
(47)
+6%
|
(41)
+11%
|
(37)
+11%
|
(32)
+14%
|
(29)
+9%
|
(34)
-17%
|
(40)
-19%
|
(43)
-7%
|
|